Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT04001504
Eligibility Criteria:
Inclusion Criteria
* Age \>= 18 years and older
* Acute coronary syndrome in hospital phase.
Exclusion Criteria:
* Participation in another clinical trial with vaccines;
* Refusal to provide consent;
* Hypersensitivity and/or anaphylaxis to any component of the vaccine, or Guillain-Barré within 6 weeks after previous influenza vaccine;
* Have already received the influenza vaccine with the same strains used in the study within the last 12 months of inclusion in the study
* Breastfeeding women;
* Pregnant women;
* Presenting an acute coronary syndrome during months of December, January, and February.
* Acute coronary syndrome hospitalization \>7 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04001504
Study Brief:
Protocol Section:
NCT04001504